Dr.Peeter Karihtala (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation

Professional Experience

• Current Role: Head Physician, Clinical Trial Unit, HUS Comprehensive Cancer Center
• Previous Positions: Various clinical and research roles at Helsinki University Hospital
• Notable Contributions: Principal Investigator for the FINPROVE trial, a nationwide precision cancer medicine initiative in Finland
• Leadership Roles: Chair of the Nordic Molecular Tumour Board, member of the Ethics Committee at HUS

Academic Contributions

• Teaching Positions: Associate Professor in Clinical Oncology at the University of Helsinki
• Research Interests: Renal cancer, early-phase drug trials, molecular profiling in cancer treatment
• Course Development: Involved in developing and delivering courses on clinical oncology and precision medicine
• Conference Engagements: Regular speaker at international oncology conferences, including ESMO and ASCO

Areas of Expertise

Dr. Jalkanen specializes in:

• Renal Cancer: Focus on molecular profiling and targeted therapies
• Early-Phase Drug Trials: Conducting clinical studies on novel cancer treatments
• Precision Medicine: Implementing personalized treatment strategies based on genetic and molecular data
• Clinical Research: Overseeing and coordinating multi-center clinical trials

Publications and Research

Dr. Jalkanen has authored over 40 peer-reviewed articles in international journals, contributing significantly to the field of oncology. Notable publications include:

• Jalkanen, K. et al. (2024). “A national precision cancer medicine implementation initiative for Finland.” Acta Oncologica. doi:10.1080/0284186X.2024.32661
• Jalkanen, K. et al. (2024). “Single intravenous administration of oncolytic adenovirus TILT-123 in patients with advanced cancer.” Journal of Experimental & Clinical Cancer Research. doi:10.1186/s13046-024-03219-0
• Jalkanen, K. et al. (2024). “National implementation of precision cancer medicine in Finland: The FINPROVE trial.” Acta Oncologica. doi:10.1080/0284186X.2024.32661

Patient Care Philosophy

Dr. Jalkanen is committed to providing compassionate and personalized care to her patients. Her approach includes:

• Patient-Centered Care: Prioritizing the needs and preferences of patients in treatment planning
• Clear Communication: Ensuring patients are well-informed about their diagnosis and treatment options
• Multidisciplinary Collaboration: Working closely with a team of specialists to deliver comprehensive care
• Support for International Patients: Offering online consultations and support for patients from abroad

Professional Affiliations

• FIGUG: Head of the Bowel Cancer Group at HUS Comprehensive Cancer Center
• Nordic Molecular Tumour Board: National Coordinator for Finland
• ESMO and ASCO: Active member of these international oncology societies
• Ethics Committee: Member of the Ethics Committee at HUS
• Certifications: Board-certified in oncology and radiotherapy in Finland

FAQs

Is Dr. Jalkanen board-certified?

Yes, she is board-certified in oncology and radiotherapy in Finland.

What types of surgeries does she perform?

Dr. Jalkanen specializes in clinical oncology and does not perform surgical procedures.

Does she treat international patients?

Yes, Dr. Jalkanen offers online consultations and supports international patients seeking treatment.

How long is the typical hospital stay?

The length of hospital stay varies depending on the treatment plan and individual patient needs.

What languages does she speak?

Dr. Jalkanen is fluent in Finnish, Swedish, and English.